How our bones develop influences our risk of osteoporosis and other skeletal disorders. In the Musculoskeletal Systems Biology Lab, led by Ronald Young Kwon, Hayden Bhavsar studies bone development by […] Read More
RANK, the primary regulator of osteoclastogenesis, mediates the effects of denosumab, an anti-RANKL antibody that provides antiresorptive therapy to millions of people affected by conditions such as osteoporosis. The drug […] Read More
Building on preliminary data showing that the gene efemp1 is dispensable for the first phase of spine mineralization—Rohda Yase will study the 2nd phase of skeletal development by determining the role […] Read More